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All G-protein-coupled receptors (GPCRs) share a common molecular architecture (with seven
putative transmembrane segments) and a common signaling mechanism, in that they interact with G
proteins (heterotrimeric GTPases) to regulate the synthesis of intracellular second messengers such as
cyclic AMP, inositol phosphates, diacylglycerol and calcium ions. Historically, GPCRs have been
classified into six families, which were thought to be unrelated; three of these are found in vertebrates.
Recent work has identified several new GCPR families and suggested the possibility of a common
evolutionary origin for all of them. Family B (the secretin-receptor family or ‘family 2’) of the GPCRs is
a small but structurally and functionally diverse group of proteins that includes receptors for
polypeptide hormones, molecules thought to mediate intercellular interactions at the plasma
membrane and a group of Drosophila proteins that regulate stress responses and longevity. Family-B
GPCRs have been found in all animal species investigated, including mammals, Caenorhabditis elegans
and Drosophila melanogaster, but not in plants, fungi or prokaryotes. In this article, I describe the
structures and functions of family-B GPCRs and propose a simplified nomenclature for these proteins.
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An overview of the relationships of GPCRs, based on the analysis reported by Graul and Sadée [5]. Families of GPCRs with
representatives in mammals are highlighted in pink.
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Figure 2
A phylogenetic tree of family-B GPCRs. Human (red), Drosophila (blue) and C. elegans (green) genes are named according to
the HUGO human gene nomenclature database [45], the Celera Publication Site [46] and WormBase [47], respectively. The




















































































































































































   4 



























   
 
    




Functions of hormone receptors in family B1
Gene name Gene product Ligand(s), with the name of the Principal functions controlled by the receptor
precursor gene in italics, where 
it is different
SCTR Secretin receptor Secretin (SCT) Secretion of HCO3-, enzymes, and K+ by the pancreas [41]
VIPR1 VPAC1 receptor VIP, Neuromodulation, T-cell differentiation
PACAP (ADCYAP1)
VIPR2 VPAC2 receptor VIP, Circadian rhythms [42]
PACAP (ADCYAP1)
ADCYAP1R1 PAC1 receptor PACAP (ADCYAP1) Glucose homeostasis, nociception, learning and memory,
circadian rhythms [29-33]
GCGR Glucagon receptor Glucagon (GCG) Hepatic glycogenolysis and gluconeogenesis, pancreatic 
secretion of insulin [41]
GHRHR Growth hormone releasing GHRH Release of pituitary growth hormone [41]
hormone (GHRH) receptor
GLP1R Glucagon-related peptide 1 GLP-1 (GCG) Pancreatic secretion of insulin and glucagon [41]
(GLP-1) receptor
GLP2R Glucagon-related peptide 2 GLP-2 (GCG) Proliferation of intestinal mucosal villus epithelium [41]
(GLP-2) receptor
GIPR Gastric inhibitory polypeptide GIP Pancreatic secretion of insulin [41]
(GIP) receptor
CRHR1 corticotropin releasing factor 1 CRF (CRH), urocortin (UCN) Secretion of ACTH [21]
(CRF1) receptor
CRHR2 Corticotropin releasing factor 2 Urocortin (UCN), Stress-related autonomic, neuroendocrine, and 
(CRF2) receptor urocortin II, behavioral function [21]
urocortin III, perhaps CRF (CRH)
PTHR1 Parathyroid hormone 1 Parathyroid hormone, PTH-related Calcium homeostasis in bone and kidney; skeletal, 
(PTH1) receptor peptide (PTHLH) pancreatic, epidermal and mammary gland 
differentiation [43,44]
PTHR2 Parathyroid hormone 2 TIP39 [22] Unknown
(PTH2) receptor
CALCRL Calcitonin receptor-like receptor Calcitonin gene related peptide Vascular tone
(CGRP: CALCA, CALCB)*; 
adrenomedullin†‡(ADM)
CALCR Calcitonin receptor Calcitonin†‡ (CALCA) Calcitonin: calcium homeostasis in bone and kidney; 
amylin*‡ (IAPP) amylin: postprandial glucagon secretion, nutrient transit
CGRP* (CALCA, CALCB) through the stomach
*When formed with accessory protein RAMP1 [23,24]; †when formed with accessory protein RAMP2 [23,24]; ‡when formed with accessory protein
RAMP3 [23,24]. VIP, vasoactive intestinal peptide; PACAP, pituitary adenylate cyclase-activating polypeptide; ADCYAPR1R1, adenylate cyclase activating
polypeptide 1 receptor 1.
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Alignment of the 7TM region of selected family-B GPCRs. The alignment was generated using the Multiple Alignment General
Interface (MAGI) suite of software (alignment using ClustalW [49], display of results using Boxshade) at the UK Human
Genome Mapping Project Resource Centre [37]. Black background indicates conserved residues; gray background indicates
similar residues; TM1-TM7 indicate transmembrane domains. See text and Table 1 for abbreviations.
BAI1        RL--STFAILAQLSADANMEKATLPSVTLIVGCG-VSSL---------TLLMLVIIYVSVWRYIRSERSVILINFCLSIISSNALILIGQTQ------------------TRNKVMCTLV
BAI2        HL--STFAVLAQPPKDLTLELAGSPSVPLVIGCA-VSCM---------ALLTLLAIYAAFWRFIKSERSIILLNFCLSILASNILILVGQSR------------------VLSKGVCTMT
ETL       
 
 HL--THFAILMSSGPSIGIKDYN--ILTRITQLGIIISL---------ICLAICIFTFWFFSEIQSTRTTIHKNLCCSLFLAELVFLVGINT------------------NTNKLFCSII
        HL--TNFAILMAHREIAYKDGVHELLLTVITWVGIVISL---------VCLAICIFTFCFFRGLQSDRNTIHKNLCINLFIAEFIFLIGIDK------------------TKYAIACPIF
        G----DQDYYYLSVKALYTVGYSTSLVTLTTAMVILCRF---------RKLHCTRNFIHMNLFVSFMLRAISVFIKDWILYAEQDSNHCF---------------------ISTVECKAV
     ------KITFYILVKAIYTLGYSVSLMSLATGSIILCLF---------RKLHCTRNYIHLNLFLSFILRAISVLVKDDVLYSSSGTLHCPDQ------------------PSSWVGCKLS
CD97        HL--SSFTILMAHYDVEDWKLTL------ITRVGLALSL---------FCLLLCILTFLLVRPIQGSRTTIHLHLCICLFVGSTIFLAGIENE----------------GGQVGLRCRLV
EMR1        QM--ANLAVIMASGELTMDFSLY-----IISHVGIIISL---------VCLVLAIATFLLCRSIRNHNTYLHLHLCVCLLLAKTLFLAGIHK------------------TDNKTGCAII
      LTNETREREVFDRLGMIYTVGYSVSLASLTVAVLILAYF---------RRLHCTRNYIHMHLFLSFMLRAVSIFVKDAVLYSGATLDEAERLTEEELRAIAQAPPPPATAAAGYAGCRVA
CELSR1      HT--ASFAVLMDISRRENGEVLP---LKIVTYAAVSLSL---------AALLVAFVLLSLVRMLRSNLHSIHKHLAVALFLSQLVFVIGINQ------------------TENPFLCTVV
       TPEKLKNAYVLYYLAIVGHSLSIFTLVISLGIFVFFRKL---------TTIFPLNWKYRKALSLGCQRVTLHKNMFLTYILNSMIIIIHLVEVV----------PNGELVRRDPVSCKIL
       KVHYHVAVIINYLGHCISLVALLVAFVLFLRLRPGCTHWGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFVVQLTMS------------PEVHQSNVGWCRLV
HE6         HL--TSFGVLLDLSRTSVLPAQMMALTFITYIGCGLSSI---------FLSVTLVTYIAFEKIRRDYPSKILIQLCAALLLLNLVFLLDSWIAL----------------YKMQGLCISV
IGHEPTA     HL--TSFSILMSPDSPDPSSLLGILLDIISYVGVGFSIL---------SLAACLVVEAVVWKSVTKNRTSYMRHTCIVNIAASLLVANTWFIVV--------AAIQDNRYILCKTACVAA
       HFDRVTLRKREYCLQHLTFADGNATSIRIAPHNCLIVPSITGQTVVMISSLICMVLTIAVYLFVKKLQNLHGKCFICYMVCLFMGYLFLLLDL-----------------WQISISFCKP
BAI1       AAFLHFFFLSSFCWVLTEAWQSYMAVTG-----HLRNRLIRKRFLCL-GWGLPALVVAISVGFTKAKG-----------YSTMNYCWLSLEGGLLYAFV--GPAAAVVLVNMVIGILVFN
BAI2       AAFLHFFFLSSFCWVLTEAWQSYLAVIG-----RMRTRLVRKRFLCL-GWGLPALVVAVSVGFTRTKG-----------YGTSSYCWLSLEGGLLYAFV--GPAAVIVLVNMLIGIIVFN
ETL        AGLLHYFFLAAFAWMCIEGIHLYLIVVG-----VIYNKGFLHKNFYIFGYLSPA-VVVGFSAALGYRY-----------YGTTKVCWLSTENNFIWSFI--GPACLIILVNLLAFGVIIY
      AGLLHFFFLAAFAWMCLEGVQLYLMLVE-----VFESEYSRKKYYYVAGYLFPA-TVVGVSAAIDYKS-----------YGTEKACWLHVDNYFIWSFI--GPVTFIILLNIIFLVITLC
     MVFFHYCVVSNYFWLFIEGLYLFTLLVE-----TFFPERRYFYWYTIIGWGTPT-VCVTVWATLRL-------------YFDDTGCWDMNDSTALWWVIK-GPVVGSIMVNFVLFIGIIV
     LVFLQYCIMANFFWLLVEGLYLHTLLV------AMLPPRRCFLAYLLIGWGLPT-VCIGAWTAARL-------------YLEDTGCWDTNDHSVPWWVIR-IPILISIIVNFVLFISIIR
CD97       AGLLHYCFLAAFCWMSLEGLELYFLVVR-----VFQGQGLSTRWLCLIGYGVPL-LIVGVSAAIYSKG-----------YGRPRYCWLDFEQGFLWSFL--GPVTFIILCNAVIFVTTVW
EMR1       AGFLHYLFLACFFWMLVEAVILFLMVRNLKVVNYFSSRNIKMLHICAFGYGLPM-LVVVISASVQPQG-----------YGMHNRCWLNTETGFIWSFL--GPVCTVIVINSLLLTWTLW
     VTFFLYFLATNYYWILVEGLYLHSLIFM-----AFFSEKKYLWGFTVFGWGLPA-VFVAVWVSVRA-------------TLANTGCWDLSSGNKKWIIQ--VPILASIVLNFILFINIVR
CELSR1     AILLHYIYMSTFAWTLVESLHVYRMLTE-----VRNIDTGPMRFYYVVGWGIPA-IVTGLAVGLDPQG-----------YGNPDFCWLSLQDTLIWSFA--GPIGAVIIINTVTSVLSAK
     HFFHQYMMACNYFWMLCEGIYLHTLIVV-----AVFTEKQRLRWYYLLGWGFPL-VPTTIHAITRA-------------VYFNDNCWLSVETHLLYIIH--GPVMAALVVNFFFLLNIVR
     TAAYNYFHVTNFFWMFGEGCYLHTAIVL-----TYSTDRLRKWMFICIGWGVPF-PIIVAWAIGKL-------------YYDNEKCWFGKRPGVYTDYIYQGPMILVLLINFIFLFNIVR
HE6        AVFLHYFLLVSFTWMGLEAFHMYLALVKV----FNTYIRKYILKFCIVGWGVPA-VVVTIILTISPDNYGLGSYGKFPNGSPDDFCWINNNAVFYITVV--GYFCVIFLLNVSMFIVVLV
IGHEPTA   TFFIHFFYLSVFFWMLTLGLMLFYRLVFI---LHETSRSTQKAIAFCLGYGCPL-AISVITLGATQPR---------EVYTRKNVCWLNWEDTKALLAFA-IPALIIVVVNITITIVVIT
      AGLGYFFVMAAFFWLSVISLHLWNTFRGSSHKANRFLFEHRFLAYNTYAWGMAV-VLTGITVLADNIVEN---QDWNPRVGHEGHCWIYTQAWSAMLYFY-GPMVFLIAFNITMFILTAK
BAI1      KLVSKDGITDKKLKERAG---------------------------------ASLWSSCVVLPLLALTWMSAVLAVTDRR----SALFQILFAVFDSLEGFVIVMVHCILRREVQDAVKCR
BAI2      KLMARDGISDKSKKQRAGSERCPWASLLLPCSACGAVPSPLLSSASARNAMASLWSSCVVLPLLALTWMSAVLAMTDRR----SVLFQALFAVFNSAQGFVITAVHCFLRREVQDVVKCQ
ETL       KVFRHTAGLKPEVSCFEN-------------------------------IRSCARGALALLFLLGTTWIFGVLHVVHA-----SVVTAYLFTVSNAFQGMFIFLFLCVLSRKIQEEYYRL
     KMVKHSNTLKPDSSRLEN-------------------------------IKSWVLGAFALLCLLGLTWSFGLLFINEE-----TIVMAYLFTIFNAFQGVFIFIFHCALQKKVRKEYGKC
   ILVQKLQSPDMGGNESSI-------------------------------YLRLARSTLLLIPLFGIHYTVFAFSPENVS----KRERLVFELGLGSFQGFVVAVLYCFLNGEVQAEIKRK
    ILLQKLTSPDVGGNDQSQ-------------------------------YKRLAKSTLLLIPLFGVHYMVFAVFPISIS----SKYQILFELCLGSFQGLVVAVLYCFLNSEVQCELKRK
CD97      KLTQKFSEINPDMKKLKK-------------------------------ARALTITAIAQLFLLGCTWVFGLFIFDDR-----SLVLTYVFTILNCLQGAFLYLLHCLLNKKVREEYRKW
EMR1      ILRQRLSSVNAEVSTLKD-------------------------------TRLLTFKAFAQLFILGCSWVLGIFQIGPV-----AGVMAYLFTIINSLQGAFIFLIHCLLNGQVREEYKRW
     VLATKLRETNAGRCDTRQ----Q--------------------------YRKLLKSTLVLMPLFGVHYIVFMATPYTEVSGTLWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKS
CELSR1    VSCQRKHHYYGKKGIVSL----------------------------------L-RTAFLLLLLISATWLLGLLAVNRD-----ALSFHYLFAIFSGLQGPFVLLFHCVLNQEVRKHLKGV
    VLVTKMRETHEAESHMYL---------------------------------KAVKATMILVPLLGIQFVVFPWRPSNKM---LGKIYDYVMHSLIHFQGFFVATIYCFCNNEVQTTVKRQ
    ILMTKLRASTTSETIQYR---------------------------------KAVKATLVLLPLLGITYMLFFVNPGEDE--VSRVVFIYFNSFLESFQGFFVSVFYCFLNSEVRSAIRKR
HE6       QLCRIKKKKQLGAQRKTS--------------------------------IQDLRSIAGLTFLLGITWGFAFFAWGPV-----NVTFMYLFAIFNTLQGFFIFIFYCVAKENVRKQWRRY
IGHEPTA   KILRPSIGDKPCKQEKSS-------------------------------LFQISKSIGVLTPLLGLTWGFGLTTVFPGT----NLVFHIIFAILNVFQGLFILLFGCLWDLKVQEALLNK
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Alignment of a putative hormone-binding domain in the extracellular region of family-B GPCRs. A conserved asparagine
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